血液科
免疫性血小板低下(ITP)
Adults with immune thrombocytopenia who switched to avatrombopag following prior treatment with eltrombopag or romiplostim: a multicentre US study. (開啟新視窗)
出處: Br J Haematol. 2022;197(3):359-66.
檢索: PubMed 35179784
DOI碼: 10.1111/bjh.18081
Efficacy of high-dose methylprednisolone as a first-line therapy in adult patients with idiopathic thrombocytopenic purpura. (開啟新視窗)
出處: Br J Haematol 1998;103(4):1061-3.
檢索: PubMed 9886319
Systematic review: efficacy and safety of rituximab for adults with idiopathic thrombocytopenic purpura. (開啟新視窗)
出處: Ann Intern Med 2007;146(1):25-33.
檢索: PubMed 17200219
Perioperative oral eltrombopag versus intravenous immunoglobulin in patients with immune thrombocytopenia: a non-inferiority, multicentre, randomised trial. (開啟新視窗)
出處: Lancet Haematol 2020;7(9):e640-8.
檢索: PubMed 32853584
DOI碼: 10.1016/S2352-3026(20)30227-1
A prospective, randomized trial of high-dose intravenous immune globulin G therapy, oral prednisone therapy, and no therapy in childhood acute immune thrombocytopenic purpura. (開啟新視窗)
出處: J Pediatr 1993;123(6):989-95.
檢索: PubMed 8229536
High-dose dexamethasone as a first- and second-line treatment of idiopathic thrombocytopenic purpura in adults. (開啟新視窗)
出處: Ann Hematol 2004;83(12):764-8.
檢索: PubMed 15309522
DOI碼: 10.1007/s00277-004-0908-1
Guidelines for the investigation and management of idiopathic thrombocytopenic purpura in adults, children and in pregnancy. (開啟新視窗)
出處: Br J Haematol 2003;120(4):574-96.
檢索: PubMed 12588344
IVMP+IVIG raises platelet counts faster than IVIG alone: results of a randomized, blinded trial in childhood ITP. (開啟新視窗)
出處: Blood Adv 2020;4(7):1492-1500.
檢索: PubMed 32282882
DOI碼: 10.1182/bloodadvances.2019001343
Initial treatment of immune thrombocytopenic purpura with high-dose dexamethasone. (開啟新視窗)
出處: N Engl J Med 2003;349(9):831-6.
檢索: PubMed 12944568
DOI碼: 10.1056/NEJMoa030254
How I treat immune thrombocytopenia: the choice between splenectomy or a medical therapy as a second-line treatment. (開啟新視窗)
出處: Blood 2012;120(5):960-9.
檢索: PubMed 22740443
DOI碼: 10.1182/blood-2011-12-309153
Use of eltrombopag for secondary immune thrombocytopenia in clinical practice. (開啟新視窗)
出處: Br J Haematol 2017;178(6):959-70.
檢索: PubMed 28573819
DOI碼: 10.1111/bjh.14788
Splenectomy for adult patients with idiopathic thrombocytopenic purpura: a systematic review to assess long-term platelet count responses, prediction of response, and surgical complications. (開啟新視窗)
出處: Blood 2004;104(9):2623-34.
檢索: PubMed 15217831
DOI碼: 10.1182/blood-2004-03-1168
Romiplostim or standard of care in patients with immune thrombocytopenia. (開啟新視窗)
出處: N Engl J Med 2010;363(20):1889-99.
檢索: PubMed 21067381
DOI碼: 10.1056/NEJMoa1002625
Therapy with high-dose dexamethasone (HD-DXM) in previously untreated patients affected by idiopathic thrombocytopenic purpura: a GIMEMA experience. (開啟新視窗)
出處: Blood 2007;109(4):1401-7.
檢索: PubMed 17077333
DOI碼: 10.1182/blood-2005-12-015222
The American Society of Hematology 2011 evidence-based practice guideline for immune thrombocytopenia. (開啟新視窗)
出處: Blood 2011;117(16):4190-207.
檢索: PubMed 21325604
DOI碼: 10.1182/blood-2010-08-302984
American Society of Hematology 2019 guidelines for immune thrombocytopenia. (開啟新視窗)
出處: Blood Adv 2019;3(23):3829-66.
檢索: PubMed 31794604
DOI碼: 10.1182/bloodadvances.2019000966
International consensus report on the investigation and management of primary immune thrombocytopenia. (開啟新視窗)
出處: Blood 2010;115(2):168-86.
檢索: PubMed 19846889
DOI碼: 10.1182/blood-2009-06-225565
Intravenous anti-D treatment of immune thrombocytopenic purpura: experience in 272 patients. (開啟新視窗)
出處: Blood 1997;89(8):2689-700.
檢索: PubMed 9108386